Objectives: to report a 6 year experience with carotid percutaneous transluminal angioplasty (CPTA) in a selected group of patients. Material and Method: we retrospectively reviewed our experience after performing 54 CPTAs, with (n=18) or without (n=36) stent deployment, over a period of 6 years from 1993 to 1999. All patients, except one, suffered from focal hemispheric neurologic symptoms. During the same time period 284 patients underwent carotid endarterectomy. The selection of the 54 patients (16%) for CPTA was based on the carotid angiogram and the sole inclusion criterion for endovascular treatment was a short, concentric, and smooth stenosis of more than 70% without ulceration or severe calcification. All patients who had a patent internal carotid artery after the last control were invited for a clinical duplex examination and all duplex examinations were carried out by a single experienced observer. Results: early outcome (<30 days): CPTA was judged technically successful in 50 cases (93%). Ten patients (18%) experienced a neurological event in relation to the procedure and one patient (2%) suffered a major stroke. One stent occluded within 30 days. Late outcome: Forty-six patients (85%) entered the follow-up study after a median of 34 months (range 1-80 months). Six patients (13%) had recurrent symptoms. The colour-duplex examination (n=45) showed internal carotid artery occlusion in 2 patients (5%), and restenosis (>70%) in 10 patients (22%). We found no significant difference in the reoccurrence of neurological symptoms or the rate of restenosis between patients treated with and without stent (Log Rank 0.28, p=0,59). ICA was patent without restenosis in 60% after 48 months in patients treated with CPTA alone, and in 76% after 3 months in patients treated with a stent (N.S.). Conclusion: CPTA in a selected group of patients has a mortality and major stroke rate comparable to that of carotid endarterectomy. However, the risk of transient neurological events was high, as well as the incidence of restenosis (>70%) after 3 years. We still consider CPTA an experimental procedure. The indications for this treatment must be clarified if CPTA should be an alternative to surgery with a comparable neurological complication rate.
Introduction
renal, iliac, superficial femoral and popliteal arteries. During the last decade PTA has also been used to treat occlusive atherosclerotic disease in the ICA. 3 This Stroke is one of the leading causes of death in the treatment was introduced in Scandinavia in 1993 4,5 but western world. 1 The risk of stroke relates to the presis still not considered a routine procedure probably ence of severe arteriosclerotic lesions in the common because reliable long-term results and well defined and internal carotid artery (ICA) and may be reduced treatment guidelines are missing. The immediate beif such lesions are removed. Currently, carotid thrombnefits of carotid PTA (CPTA) vs CEA include short endarterectomy (CEA) is the treatment of choice in treatment duration, no need of general anaesthesia severe (>70%) symptomatic stenoses in the ICA beand avoidance of surgical stress as well as possible cause it reduces the risk of ipsilateral stroke by 17% complications following surgical treatment, e.g. periafter 2 years. 2 pheral nerve lesions and haemorrage. Despite the lack Percutaneous transluminal angioplasty (PTA) with of clear evidence, it is assumed that the perioperative or without stent deployment is an established treatmortality and morbidity following CPTA is comment of occlusive atherosclerotic disease in coronary, parable with CEA. 1 The purpose of this retrospective investigation was to evaluate safety and efficiency of Material and Methods PTA, while 18 (33%) also had a stent deployed. After endovascular treatment all patients were observed During the time when this study was undertaken for 3-4 days, and continuously treated with ASA (100-150 mg/day) or ASA (100-150 mg/day) and di-patients suspected of having a symptomatic ICA stenosis were referred to the Department of Neurology pyridamol (200 mg/day).
During the introduction of this new treatment stents where they were screened by transcranial Doppler or by duplex scanning. If a symptomatic stenosis was were only used in case of residual stenosis (>50%) and recoil (n=1), dissection or significant irregularities of suspected the patient was referred to angiography. During the period May 1993-October 1999 ap-the artery wall after PTA (n=7). After July 1998 stents were used more routinely. Three different types were proximately 600 patients underwent angiography. The indication for surgical or endovascular treatment, was used: the balloon-expandable Palmaz stent (Johnson & Johnson  ) (n=7), the self-expandable Easy Wallstent  a high-grade stenosis (>70%) on angiography which was found in 338 patients. The inclusion criteria for (Schneider) (n=10) and the self-expandable Multilink  stent (ACS) (n=1). Two lesions were treated with CPTA were sharply defined based exclusively on angiography: the stenosis had to be short (<1 cm), double stents.
Neurological events during and immediately after concentric, smooth, and without ulceration or severe calcification to provide optimal treatment conditions treatment were recorded in three categories: (1) TIA and amaurosis fugax which resolved within 24 h; (2) for the balloon procedure. Fifty-four ICAs were treated with CPTA in 54 (16%) patients and 284 (84%) patients minor stroke causing minimal neurological deficit without loss of the functional ability which resolved underwent CEA. The indication for endovascular treatment in one case, however, was an asymptomatic 95% within 30 days and (3) major stroke defined as deficits lasting more than 30 days with changes in the lifestyle stenosis in the left ICA in a patient who was treated prior to coronary artery bypass surgery. Fifty-three of the patient. 6 Twenty-three of the first 24 patients were followed-patients had an atherosclerotic lesion and one patient had a stenosis secondary to irradiation of the neck for up with duplex scanning and clinical examination in 1997. 4 Thus, the present study includes all the patients tonsillary cancer. Male/female ratio was 37/17 and the median age was 64 years (range 36-78). Thirty-from the former study with patent ICA in 1997 (n=23) and, in addition, patients treated succesfully between one (57%) patients were smokers, 20 (37%) were treated with antihypertensive medication, 13 (24%) had isch-1997 and November 1999 (n=30). Forty-six patients (85%) participated in a clinical examination and 45 aemic heart disease, 10 (19%) had intermittent claudication, 5 (9%) had diabetes mellitus and 5 (9%) were patients (83%) also underwent a colour duplex reexamination at the beginning of the year 2000. One treated for hypercholesterolaemia.
All patients except one had a symptomatic severe patient was evaluated clinically only, and eight did not participate in the follow-up: one patient had died lesion (>70%) in the ICA: 11 patients suffered from amaurosis fugax (20%), 8 of which (15%) also had due to pancreatic cancer, two refused to participate, three were treated with CEA after CPTA because of transitoric ischaemic attacks (TIA), 13 (24%) patients had isolated TIA, and 21 (39%) patients had suffered recurrence of a symptomatic stenosis and one had an occluded ICA. In the last patient CPTA of a restenosis from a minor stroke. Preoperative angiography demonstrated a stenosis greater than 90% in 40 (74%) in the ICA one year after CEA was technically unsuccesful and the patient is presently treated medically patients and a stenosis between 71% and 89% in 14 (26%) patients. The criteria for assessment of the sten-with aspirin and dipyridamol.
Duplex scanning was performed with the patients osis in the ICA were the same as used in the NASCET study.
in supine position. All examinations were performed by the same experienced physician. We used a Siemens All the patients received aspirin (ASA) (100-150 mg×1) or ASA and dipyridamole Sonoline Elegra  ultrasound system with a 5 Mhz linear array transducer and the angle of insonation never (200 mg×2) prior to angiography. All were catheterised through the femoral artery. Heparin (5000 IU) exceeded 55°. ICA stenosis were evaluated according to the criteria of Zweibel. 7 For a stenosis of 60-79% was administrated intraarterially immediately prior to CPTA. The size of the PTA balloon matched the normal the reference values were a peak velocity >130 cm/ sec, end-diastolic velocity >40 cm/sec, systolic velocity ICA diameter distal to the stenosis and ranged from 3-6 mm. We considered the PTA procedure technically ratio (ICA/CCA) >1.8 and diastolic velocity ratio (ICA/CCA) >2.4. For a stenosis of 80-99% the reference succesfull if any residual stenosis was less than 50%. Thirty six (67%) lesions were treated exclusively with values were a peak velocity >250 cm/sec, end-diastolic velocity >100 cm/sec, systolic velocity ratio (ICA/ four of the symptomatic patients (9% of all examined patients) had a significant restenosis (>70%) in the CCA) >3.7 and diastolic velocity ratio (ICA/CCA) >5.5. treated ICA while there was no restenosis in two patients. The latter two patients had a history of isch-Statistical analysis included calculation of the restenosis-free interval by means of Kaplan-Meier sur-aemic heart disease with arrythmias.
Overall, in the 45 patients who underwent colour vival analysis using the intention to treat principle. The two groups were compared using the Log Rank duplex scanning we found a stenosis between 50% and 70% in 6 patients (13%), significant restenosis method.
(>70%) in ten (22%) and ICA occlusion in two patients (5%). The incidence of significant restenosis during the follow-up in patients treated with or without stent Results deployment was 13% and 25%, respectively. If occlusions were included the incidence rates would be Early outcome (<30 days) 20% and 29%, respectively. Furthermore, the median follow up time in the former group was considerably CPTA with or without stent, was primarily technically shorter than in the latter (44 months vs 14 months). successful in 50 (93%) patients. Control angiography All patients except three (the one who died and the showed a minor residual stenosis (<50%) in seven two who refused to participate) were included in a (13%) patients. CPTA was not technically possible in Kaplan-Meier survival analysis on an intention to three (6%) patients because of a tight stenosis which treat principle. This analysis revealed a restenosis-free did not allow catherisation. Two of these later underinterval of 60% after 48 months (SEE 9%) in the CPTA went CEA whereas the third was treated medically group. In the CPTA with stent group the shorter with aspirin and dipyridamole which he had not observation period only allowed calculation of a rerecieved earlier. In another patient the artery recoiled stenosis-free interval of after 9 months which was 79% after PTA. He became symptomatic with episodes of (SEE 11%) (Fig. 1) . TIA and was treated with CEA. In one patient the endovascular stent occluded on the fourth day causing transient neurologic symptoms but thereafter he be-Discussion came asymptomatic.
The perioperative CPTA mortality (30 days) was CEA is considered the gold standard for treatment of zero. Neurological events were recorded in ten (18%) ICA lesions to reduce the risk of stroke in patients patients during or immediatedly following the enwith a symptomatic significant stenosis. 2,8 With time, dovascular procedure. One patient (2%) had an epihowever, the technical improvements have increased sode of amaurosis fugax, and six (11%) had episodes the use of endovascular treatments of these lesions. of TIA. Two (4%) patients suffered a minor stroke and CPTA with or without stent deployment, has been one (2%) a major stroke. In addition, six (11%) patients used to treat both symptomatic and asymptomatic were treated succesfully with intravenous atropin bearteriosclerotic lesions in the common carotid and ICA cause of bradycardia during the procedure and one since 1979. 9 The main concern with the technique has patient was shortly unconcious presumably due to been the risk of cerebral embolic episodes. cerebral hypoperfusion because the contralateral ICA The combined incidence of mortality and major was occluded.The rate of neurological events was stroke from endovascular treatment of ICA lesions similar in the initial (5 events/24 procedures) and late varies between 1-9%. 9-14 Kritpracha and Beebe reperiode (5 events/30 procedures) after the introduction viewed and summarised experiences of 14 non-ranof the CPTA in our department. domised and non-controlled studies and did not draw any conclusion because many series did not provide adequate information about the patients, the indications for treatment, the complications or the fol-Late outcome low-up time. Their short report, however, revealed that mortality and morbidity accounts for up to 30% After a median follow-up of 34 months (range 1-80 months), 40 (87%) patients were asymptomatic and and the risk of neurological deficits seems to be less after stent deployment compared with PTA alone. 15 six (13%) had symptoms: TIA+amaurosis fugax (n= 1), TIA alone (n=4) or major stroke (n=1) ( Table 1) .
One of the two randomised studies so far, the CA-VATAS investigation, as yet unpublished, found a Colour duplex sonography (45 cases) revealed that found a combined risk of death or major stroke of 3.1% while the risk increased to 5.8% if minor stroke was included. 2 The incidence of transient neurological events (TIA and amaurosis fugax), however, was considerably higher in our study than has been reported in most previous studies. One reason for this difference could be selection bias since many investigators included 40-60% asymptomatic patients with severe ICA lesions. 13, 14 At the beginning of our study period we only used stents when the results of CPTA were sub-optimal, e.g. recoil, dissection or irregular vessel wall. We later changed our strategy, like others, and used stents more routinely. 1,3,20 A stent may reduce the risk of microembolisation, residual stenosis and possibly also the rate of restenosis. 1, 3, 14, [20] [21] [22] The procedural time duration of stent placement is short and consequently the risk of cerebral ischaemia due to interruption of blood flow is reduced. 5 Various types of stents have been used in the ICA. We used the balloon expandable Palmaz stent (Johnson & Johnson  ) in the early phase of the treatment period Fig. 1 . Calculation of the restenosis-free interval by use of Kaplanand only the self expandable Easy Wallstent Meier survival analysis in patients treated with CPTA alone or (Schneider  ) for the last years. The thermosensitive CPTA and stent (Intention to treat principle). All patients except three (the one who died and the two who refused to participate) self expandable nitinol stents are the preferred stents were included in the analysis. by interventional radiologists in other vascular territories. 9,11,14,23 These stents are flexible, have a low thrombogenecity, a tight mesh and are transparent. combined risk of stroke (major and minor) and death
The Palmaz stent is made from stainless steel. Because higher than 10% after angioplasty and concluded that it is rigid and needs dilatation from a balloon it may angioplasty is as safe as surgery. [16] [17] [18] The second ranresult in microembolisation. 9 Deformation of the Paldomised study from Leicester has been suspended maz stent from external compression has been debecause 5 of the 7 patients who who underwent CPTA scribed in the literature with an incidence of stent had a stroke. 18, 19 collapse between 1% and 16%. 9,11,14,23 Therefore, we do Our results reveal a death and stroke rate (major and minor) of 5%. In comparison, the NASCET study not use it any more.
